Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
NA |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
AT , NADPH oxidase inhibitors ( apocynin and diphenyleneiodonium chloride [ DPI ] ) , and an inhibitor to PKC alpha and other isoforms ( 2 , 2 ' , 3 , 3 ' , 4 , 4 ' hexahydroxy 1 , 1 ' biphenyl 6 , 6 ' dimethanol dimethyl ether [ HBDDE ] ) but not PKC beta 2 ( LY 379196 ) decreased O ( 2 ) ( ) release and p47phox translocation . ^^^ |
|
Interacting proteins: P05771 and Q06187 |
Pubmed |
SVM Score :0.0 |
At the LVF stage , however , PKC epsilon returned to the control level , whereas PKC beta 1 and beta 2 increased by 158 % and 155 % , respectively . ^^^ |
|